Diseases & Disorders
(G48)
990 on File
GREENVILLE NEUROMODULATION CENTERINC
Financial strength (30%)
61/100
Reliability (20%)
50/100
Effectiveness (25%)
21/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$114K
Total Revenue
$128K
Total Expenses
$446K
Net Assets
N/A
Employees
Program Expense Ratio
0.0%
Fundraising Efficiency
N/A
Operating Reserve
41.70x
Liability-to-Asset
49.6%
Revenue Diversification
N/A
Executive Compensation
$0
Compared with Peers
FY 2024
Compared with 1,541 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 83.1% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
41.7 mo | 12.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
49.6% | 0.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
11.2% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-26.0% | 9.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-12.8% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $114K | $128K | $446K | 0.0% | — |
| 2023 | $102K | $173K | $461K | 0.0% | — |
| 2022 | $102K | $143K | $532K | 7.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.